cp 93129 has been researched along with quipazine in 2 studies
| Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (quipazine) | Trials (quipazine) | Recent Studies (post-2010) (quipazine) |
|---|---|---|---|---|---|
| 109 | 0 | 11 | 658 | 0 | 41 |
| Protein | Taxonomy | cp 93129 (IC50) | quipazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 1.4454 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.47 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.4 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.7 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0617 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.7297 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0035 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 3.7153 | |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | 1.4454 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 3.4674 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhot, MC; Cassel, JC; Jackisch, R; Riegert, C; Rothmaier, AK; Rutz, S | 1 |
| Jackisch, R; Riegert, C; Rothmaier, AK; Rutz, S | 1 |
2 other study(ies) available for cp 93129 and quipazine
| Article | Year |
|---|---|
Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice.
Topics: Acetylcholine; Analysis of Variance; Animals; Cerebral Cortex; Choline; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; Male; Mice; Mice, Knockout; Presynaptic Terminals; Pyridines; Pyrroles; Quipazine; Receptor, Serotonin, 5-HT1B; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2006 |
Presynaptic modulation of 5-HT release in the rat septal region.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Brimonidine Tartrate; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; In Vitro Techniques; Male; Neurons; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Quipazine; Rats; Rats, Wistar; Septum of Brain; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2007 |